Makerere University School of Health Sciences, is one of the schools that constitute Makerere University College of Health Sciences, a semi-autonomous constituent college of Makerere University, Uganda's oldest university.

During the past decade, Makerere University Medical School conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Makerere University Medical School" #1 sponsor was "Centers for Disease Control and Prevention" with 5 trials, followed by "Makerere University" with 5 trials sponsored, "Charite University, Berlin, Germany" with 1 trials sponsored, "Imara, Inc." with 1 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Makerere University Medical School" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Makerere University" with 2 trials as a collaborator, "US Department of Veterans Affairs" with 2 trials as a collaborator, "African Community Center for Social Sustainability" with 1 trials as a collaborator and "Global Alliance for TB Drug Development" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Makerere University Medical School" are "Tuberculosis" (4 trials), "Acute Asthma" (1 trials), "Bacterial Pneumonia" (1 trials), "Cryptosporidiosis" (1 trials) and "HIV" (1 trials). Many other conditions were trialed in "Makerere University Medical School" in a lesser frequency.

Most popular intervention types in "Makerere University Medical School" are "Drug" (9 trials), "Other" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abacavir" (1 trials), "Ampicillin" (1 trials), "Blood pressure management in the HIV program" (1 trials) and "Ceftriaxone Sodium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Makerere University Medical School" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Makerere University Medical School". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Makerere University Medical School, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Makerere University Medical School, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".